Genmab(GMAB) - 2024 Q1 - Earnings Call Transcript

Jan van de Winkel – Chief Executive Officer Anthony Mancini – Chief Operating Officer Anthony Pagano – Chief Financial Officer Tahi Ahmadi – Chief Medical Officer Judith Klimovsky – Chief Development Officer Operator I would now like to hand the conference over to your first speaker today, Jan van de Winkel. Please go ahead. Before we look at our first quarter results, I want to remind you of our consistent track record of success. Our proprietary technologies fuel our robust product pipeline which is both ...